Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers.
- DOI
- 10.2174/1574892811666160519113731
- Published
- 2016
- Container
- Recent patents on anti-cancer drug discovery
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2174/1574892811666160519113731,
title = {Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers.},
author = {Fouqué A and Jean M and Weghe Pv and Legembre P},
year = {2016},
journal = {Recent patents on anti-cancer drug discovery},
doi = {10.2174/1574892811666160519113731},
url = {https://doi.org/10.2174/1574892811666160519113731}
}RIS
TY - JOUR TI - Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers. AU - Fouqué A AU - Jean M AU - Weghe Pv AU - Legembre P PY - 2016 JO - Recent patents on anti-cancer drug discovery DO - 10.2174/1574892811666160519113731 UR - https://doi.org/10.2174/1574892811666160519113731 ER -
APA
A, F., M, J., Pv, W., & P, L. (2016). Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers.. Recent patents on anti-cancer drug discovery. https://doi.org/10.2174/1574892811666160519113731
Source records
- pubmed · retrieved 2026-11-10T12:42:06.618Z